Previous studies indicated that most patients with E. coli-asparaginase allergy also have a neutralizing antibody to the enzyme, resulting in sub-therapeutic systemic asparaginase activity even if allergic symptoms are prevented by the use of antihistamines and other premedications34, 35, 36, 37, 38. This evidence concerns the gene ASPG and Allergy.